Analyst Report: LMT

1. EXECUTIVE SUMMARY

Lockheed Martin closed at $635.20 on Monday October 26, 2026, up 15.86% over the week from $548.23 on October 19. Three sessions drove the gain. The stock rose 6.96% on October 22 after third-quarter results beat and full-year guidance rose for the second consecutive quarter, and the Pentagon announced a 10-year F-35 framework agreement the same day. It added 2.42% on October 23 with no new company event in the sources, and it gained 5.13% on October 26 when Morgan Stanley upgraded the shares to Overweight with a $835 target, citing the F-35 agreement as removing a key risk. The framework is not a formal procurement contract, and pricing, aircraft numbers and congressional funding remain open, so the rally rests on a deal still to be finalised. The shares trade at a forward P/E of 19.1 and sit 7.0% below the March 52-week high of $683.27.

2. THE CATALYST

Two events broke on October 22, and a third arrived on October 26.

Q3 results (October 22). According to Lockheed's press release, sales were $20.7bn, up 11% from $18.6bn a year earlier. Net earnings rose 14% to $1.8bn, or $7.97 per share against $6.95. Backlog reached a record $292.0bn and free cash flow was $3.0bn. Consensus sources differ: Investing.com cites EPS of $7.52 and revenue of $20.48bn, while Reuters, relayed by Quartz, cites $7.43 and $20.51bn. Either way, the reported figures came in above both.

Source: Benzinga and Quartz, October 22. Quartz also reported that Missiles and Fire Control sales rose 24% to $4.5bn on PAC-3 and THAAD ramps. Benzinga reported a slight trim to Aeronautics guidance because of revised F-35 award-timing expectations. The company also said it will raise its dividend for the 24th consecutive year.

F-35 framework (October 22). Breaking Defense and The Aviationist reported that the Pentagon and Lockheed reached a 10-year framework covering at least 850 US jets across Lots 21–30, at 156 aircraft a year. Neither side disclosed a contract value, and Stripes reported the Pentagon's statement that Lockheed will self-fund at least $7bn in F-35-related initiatives. Some trade outlets cite "up to 1,560" aircraft, a figure that appears only in secondary reporting and conflicts with the official sources.

Morgan Stanley upgrade (October 26). Benzinga and Investing.com reported that Kristine Liwag raised the rating from Equal-Weight to Overweight and the target from $690 to $835, arguing that the F-35 agreement significantly de-risks the stock. My source access to the Yahoo summary was limited, so this rests on those two reports.

The session on October 23 followed through on analyst notes and the earnings beat without a new company event in the sources.

3. COMPANY PROFILE

Lockheed Martin is an aerospace and defense company in the Industrials sector with four segments: Aeronautics (combat and air mobility aircraft, including the F-35), Missiles and Fire Control, Rotary and Mission Systems, and Space. Its market cap is $146.73bn, with a trailing P/E of 21.5 and a dividend yield of 2.38%. Peers in the group include Northrop Grumman, General Dynamics, RTX and Boeing.

Management cited munitions production ramps and F-35 program stability in raising guidance, according to the Motley Fool transcript. The raise followed an earlier one in July. Lockheed also claims the framework supports about 317,000 US jobs and about $79bn in annual economic activity over the decade (Janes). That figure is the company's own claim.

4. DEEP DIVE ANALYSIS

Fundamentals. The quarter supports a higher valuation. Sales growth of 11%, a record backlog and a second consecutive guidance raise are concrete. Missiles and Fire Control, growing 24%, shows demand for air defense systems feeding directly into revenue. The F-35 agreement adds multi-year visibility on the company's largest program, though it carries no disclosed value.

Size of the move. The stock had risen 22.60% over 20 sessions and 30.10% year to date, and is 17.4% above its 200-day average of $561.62. Part of the October 26 gain followed a rating change rather than new company information, since the F-35 framework had been public for four days. This is inference, but the volume pattern fits it: 2,666,700 shares on October 26, 2.23x the 50-session average.

Peers. Northrop Grumman rose 10.72% over the same period, General Dynamics 4.57% and RTX 2.80%, while Boeing fell 1.62%, GE 7.34% and Howmet 11.67%. The S&P 500 slipped 0.18%. The brief found no peer-specific news explaining the group's moves. Strength in the pure defense primes beside weakness in commercial aerospace names fits a defense-specific driver, which is inference.

Analyst reaction. Targets rose broadly, yet most ratings stayed cautious.

The close of $635.20 exceeds the targets of Deutsche Bank, BofA and RBC, and sits below UBS at $692 and Citigroup at $706. BofA flagged cash-flow risk after the report.

Bull case. Multi-year F-35 visibility, rising munitions output and a backlog of $292.0bn support earnings growth, and Morgan Stanley's $835 target sits well above the price.

Bear case. The framework needs congressional authorization and funding, the Aeronautics guidance was trimmed, and three of the four firms with ratings below Buy hold targets under the current price.

The brief found no earlier F-35 framework episode that moved the stock comparably.

5. TECHNICAL SNAPSHOT

The close of $635.20 is the highest in the daily table and sits well above the 50-day average of $539.89 and the 200-day average of $561.62, after a climb from $504.02 on October 13. It remains below the 52-week high of $683.27 set on March 2, and far above the low of $429.47 from December 2, 2025. Volume of 2,957,700 on October 22 and 2,666,700 on October 26 ran above the 50-session average of 1,194,196, so both big gains drew heavy participation. The latest close is the highest in the table, so no resistance level is named from the closes; the March high is the next reference. The nearest support from the closes is $604.18 from October 23.

6. RISK FACTORS

• The F-35 framework is not a procurement contract. Pricing and aircraft numbers still have to be negotiated, and neither side disclosed a value.
• Congressional authorization and appropriations are required. The House passed its FY2027 NDAA in July, and the Senate version was pending as of October 23. Both contain provisions that would authorize multiyear F-35 procurement (The Aviationist).
• Lockheed has said it will finalise pricing and schedules with the F-35 Joint Program Office once authority and appropriations arrive (The Aviation Hub). No date has been given.
• BofA flagged cash-flow risk, and Lockheed must self-fund at least $7bn in F-35-related initiatives.
• The stock sits above three of the seven analyst targets after a 22.60% gain in 20 sessions.
• The brief found no sourced date for the next earnings report or an investor event.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks). After three strong sessions and a 2.23x volume spike, the shares face a test of the $604.18 level from October 23. Further target revisions and the Senate NDAA progress are the near-term news. Further gains would need new evidence beyond the upgrade, since the framework terms were public on October 22.

Medium term (1-3 months). Congressional action on the framework and the turn into formal pricing talks decide the direction. Authorization and appropriations on schedule would support the Morgan Stanley view, while delays or a lower price per aircraft would weigh on the shares. Guidance raised twice in a row sets a higher bar for the next report.

Long term. The thesis of rising munitions demand and a stable F-35 program has strengthened, with a record backlog and a 10-year framework. Its value depends on terms not yet negotiated. This is analysis and not personal financial advice.